Wharton's Jelly
Instead of adding another separate ECM or filler step, providers get a single Wharton's Jelly-based human biologic that fits directly into current orthopedic, wound care, spine, sports medicine, and aesthetic services.
- Exosomes
- 200+ Growth Factors
Biologically active cytokines
Natural human collagen- Natural human hyaluronic acid
- Chondroitin sulfate
- Full Lot & Donor Traceability
How It Works
Wharton's Jelly is the gelatinous connective tissue within the umbilical cord, naturally rich in collagen, hyaluronic acid, chondroitin sulfate, and Exosomes. Processed into MXT-002 using proprietary technique with no enzymes added, it retains this matrix as a ready-to-use, human-derived biologic.
For providers, that means Wharton's Jelly works in synergy with procedures already on the menu, used alone, or layered into orthopedic, wound care, spine, sports medicine, and aesthetic protocols to soothe and enhance the results patients already expect. Because MXT-002 arrives pre-processed and ready to administer, it adds to a service menu without the onsite processing or added chair time that comes with harvesting a patient's own tissue, making it as much a replacement for labor-intensive protocols as it is an enhancement to existing ones.
Testing & Safety
Clinical Applications
Orthopedic
Joint, tendon, and cartilage support through ECM scaffolding and growth factor delivery for connective tissue repair and inflammation modulation.
Wound Healing
Chronic and acute wound management leveraging natural hyaluronic acid and collagen matrix to support tissue regeneration and healing.
Spine
Disc and spinal tissue support applications utilizing the cushioning and structural properties of Wharton’s Jelly matrix.
Sports Medicine
Athletic injury recovery and performance restoration through targeted growth factor delivery to damaged musculoskeletal tissues.
Aesthetics
Skin rejuvenation and facial restoration protocols leveraging the natural hyaluronic acid and collagen content for volume and hydration support.
Dental
Oral surgery recovery, bone grafting support, and periodontal tissue regeneration through ECM-based scaffolding and growth factor signaling.
Donor Infectious Disease Screening (11-Panel)
CMV Total Antibody
HBV Core Antibody (Hepatitis B Virus)
Hepatitis B Surface Antigen
Syphilis Screening (Non-treponemal)
HBV NAT/PCR
HTLV (Types I and II)
HCV Encoded Antigens (Hepatitis C Virus)
WNV (West Nile Virus)
HCV NAT/PCR
HIV (Types 1 & 2, plus O)
HIV-1/2 NAT/PCR
All testing is performed according to CDC, FDA, and US Organ Procurement and Transplantation Network policies. Donors are rejected for any reactive, positive, or equivocal result and accepted only when results are nonreactive, negative, or non-equivocal.
Compliance & Regulatory
Partner with us.
Whether you run a med spa, surgical suite, clinical practice, or wellness center. Sōlix gives you the science, the support, and the platform to offer your patients something better.